Skip to main content
Tech.euFundingExplorerBeta

Cellsway

a spin-off of the METU BioMEMS research group in 2015

Cellsway has raised €200k across 2 funding rounds from 2 investors, most recently a round in Aug 2024. Based in Cheshire, UK; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€200k
€200,000
Funding rounds
2
Investors
2
distinct backers
Active since
2023-10
latest 2024-08

Funding by year

EUR raised per year
Cellsway — funding by year — interactive chart.
Data table
Cellsway — funding by year
2023€200k
2024€0

Signals

Medium confidence
Raise-next likelihood20
base rate 30% for Other
  • ▼ Past typical raise window
  • ▼ Low backer re-investment
Exit likelihood5
base rate 11% (2+ rounds)
  • ▼ No recent equity round (debt-only or quiet)

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2024-08-22Other—Technology and Innovation FundView deal →
2023-10-09Other€200kAPY VenturesView deal →

Similar companies

same sector or country
  • Nscale
    UK · Cloud
    €11B
  • Arm
    UK · Semiconductors
    €4.7B
  • DAZN
    UK · Software
    €3.8B
  • SumUp
    UK · Fintech
    €3.5B
  • CityFibre
    UK · Telecom
    €3.0B
  • Philips
    Netherlands · Healthtech
    €2.6B

Global coverage: FundingData